India to supply HCQ to Nepal, Bhutan and Bangladesh

On supply of medicines, India has said it will supply hydroxychloroquine (HCQ) and other medicines to Nepal, Bhutan and Bangladesh as they completely depend on the country for pharmaceuticals at a virtual meeting among SAARC trade officials.

This was discussed at the virtual meeting among SAARC trade officials on Wednesday, a day after India relaxed the ban on exports of paracetamol and HCQ, both used in Covid-19 therapies, and placed them in the licensed category.

“We will help these countries especially Nepal and Bhutan as they have been completely dependent on us for many products,” said an official.

SAARC nations particularly Nepal were among the 30 countries who had asked India to lift the ban on the export of HCQ.

Sponsored Stories

Subscribe to our Newsletters

When the blood reaches these curves, it makes changes to its fluid mechanics and interactions with the vessel wall. In a healthy person, these changes are in harmony with the tortuous microenvironment, but when diseased, these environments could lead to very complex flow conditions that activate proteins and cells that eventually lead to blood clots.